Marengo Asia Healthcare and Karkinos Healthcare join hands to address the cancer challenge in India through the message centred around “Let’s win over Cancer”, enabling a long-term, sustainable, socio-economic impact in the onco-care ecosystem.
This strategic partnership aims to lay the groundwork for systematic population screening for common cancers through the importance of early detection coupled with precision diagnosis capabilities and personalised treatment, which is a key to understanding individual cancer proliferation and plan treatment.
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers through an integrated cancer care network as part of the partnership alongside Marengo Asia network hospitals.
Speaking on the partnership, Dr Raajiv Singhal, Founding Member, MD & CEO, Marengo Asia Healthcare says, “Every patient detected with Cancer should be treated at right time. Our focus is to create a positive impact in the society we live in by working with all our stakeholders. It is well known that there are 2.25 million cases detected with cancer each year, with cancer affecting at least 1 in 8 Indians in their lifetime. With this partnership, we aim to reduce the mortality and morbidity in the societies around Marengo Asia hospitals thus creating social and economic benefits to patients and their families. With cancer emerging in the recent years as a major public concern in India, this partnership is directed, with advanced technology in diagnostics, a significant break-through in early detection and decreased burden of deaths due to cancer.”
“Cancer care continues to be one of the most critical and yet underserved needs in our country. Every year, millions of new cases are diagnosed, and with partnering like minded organisations such as Marengo Asia Healthcare, we hope to revolutionise the existing paradigms of patient care. The prime focus of Karkinos Healthcare is to create awareness and provide platform for early detection and diagnosis of cancer, with a vision towards precision oncology. And coming together of our organizations is a unique proposition for patients and communities in addressing early detection, precision cancer care plan treatment as well as post-op care,” adds Dr Moni Kuriakose, Co-Founder and Medical Director, Karkinos Healthcare.
The complex and rare cancer cases will be discussed in Virtual Tumor Board (VTB), which has national and international oncology experts of eminence assuring right and trusted cancer care to patients. The approach is to make sustainable impact in community by empowering people to self-detect any signs of cancer in their family and make super-specialised treatments accessible and affordable.
The organisations will continue to stay engaged in academics, research, and innovation to drive precision oncology treatments solutions with evidence-based approach through population analytics.
